Table:
begin	end	state
1	27	cytoplasmic
28	51	transmembrane
52	66	non-cytoplasmic
67	87	transmembrane
88	98	cytoplasmic
99	119	transmembrane
120	125	non-cytoplasmic
126	151	transmembrane
152	162	cytoplasmic
163	186	transmembrane
187	197	non-cytoplasmic
198	217	transmembrane
218	251	cytoplasmic
252	274	transmembrane
275	292	non-cytoplasmic
293	311	transmembrane
312	318	cytoplasmic
319	338	transmembrane
339	343	non-cytoplasmic
344	367	transmembrane
368	378	cytoplasmic
379	402	transmembrane
403	408	non-cytoplasmic
409	428	transmembrane
429	432	cytoplasmic

Input:
>Pf1N1B4_2033 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2033
MTTAPSSIAQPTQSTRPLTRNDYKTLSLSALGGALEFYDFIIFVFFATVVGKLFFPADMP
EWLRLMQTFGIFAAGYLARPLGGIVMAHFGDLLGRKKMFTLSIFMMAVPTLIMGLLPTYA
QIGMWAPILLLLMRVIQGAAIGGEVPGAWVFVSEHVPQRHIGYACGTLTSGLTAGILLGS
LVATAINSIYTPVEVSDYAWRIPFLLGGVFGLFSVYLRRWLHETPVFAELQLRKALAEEV
PLRAVLRDHRGAILISMLLTWLLSAAIVVLILMTPTVLQTVYHFAPTTALQSNSVAIVLL
SIGCIIAGALADRFGAGRVFVFGCAALLVSSWTFYHSLAEHPDWLFPMYAITGLLVGTIG
AVPYVMVKAFPPVVRFSGLSFSYNVAYAIFGGLTPMIVSLLLKESPMGPAYYVAVLCGVG
ILVGAYLWKKGR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server